Sumatriptan succinate
CAS No. 103628-48-4
Sumatriptan succinate ( GR 43175C )
Catalog No. M10181 CAS No. 103628-48-4
Sumatriptan succinate is a serotonin1 (5-HT1) receptor agonist, which is effective in the acute treatment of migraine headache.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
25MG | 37 | In Stock |
|
50MG | 53 | In Stock |
|
100MG | 77 | In Stock |
|
200MG | 105 | In Stock |
|
500MG | 230 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSumatriptan succinate
-
NoteResearch use only, not for human use.
-
Brief DescriptionSumatriptan succinate is a serotonin1 (5-HT1) receptor agonist, which is effective in the acute treatment of migraine headache.
-
DescriptionSumatriptan succinate is a serotonin1 (5-HT1) receptor agonist, which is effective in the acute treatment of migraine headache.
-
SynonymsGR 43175C
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number103628-48-4
-
Formula Weight413.49
-
Molecular FormulaC18H27N3O6S
-
Purity>98%(HPLC)
-
SolubilityWater: 83 mg/mL (200.73 mM); DMSO: 83 mg/mL (200.73 mM)
-
SMILESOC(=O)CCC(O)=O.CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Peroutka SJ, et al. Eur J Pharmacol, 1989, 163(1), 133-136.
molnova catalog
related products
-
Cannabigerol
Cannabigerol is a high affinity α±2-adrenergic receptor agonist, moderate affinity 5-HT1A receptor antagonist, and low affinity CB1 receptor antagonist ; also binds to the CB2 receptor; it can relieve interocular pressure, which may be of benefit in the treatment of glaucoma.
-
SB-258585
SB-258585 is a potent, selective and orally active 5-HT6 receptor antagonist with Ki of 8.9 nM.
-
Donitriptan hydrochl...
Donitriptan hydrochloride is a potent, high efficacy agonist of 5-HT1B/1D receptors with pKis of 9.4 and 9.3, respectively.